Inventor · disambiguated record
John William Giraldes
Also filed as: GIRALDES JOHN · GIRALDES JOHN WILLIAM
8 granted patents·1 pending application·47 citations·filing 2010–2021
85Inventor score
Top patents by PatentIndex Score
9 records- 0192US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0292US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0390US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0488US9309252B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2014·Granted Apr 12, 2016·12 cites·18 claims
- 0585US8957074B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Granted Feb 17, 2015·9 cites·40 claims
- 0677US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 0775US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 0874US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 0963US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when John William Giraldes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →